Lewes, DE -- (SBWIRE) -- 09/12/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Dephasium Corp (OTCMKTS: DPHS), GDF Suez SA (ADR) (OTCMKTS: GDFZY), Australia and New Zealand Banking (ADR) (OTCMKTS: ANZBY), Titan Pharmaceuticals, Inc. (OTCBB: TTNP).
Dephasium Corp (OTCMKTS: DPHS) decreased -11.89% and closed at $0.0326 on a traded volume of 1.30 million shares, in comparison to 1.06 million shares of average trading volume. So far this year, the stock is down over -74.92%.
The company has a total market capitalization of $3.75 Million and its total outstanding shares are 114.96 million
Will DPHS Get Buyers Even After The Recent Rally? Find Out Here
Dephasium Ltd. designs and manufactures Smartphone cases for protection against electromagnetic waves.
GDF Suez SA (ADR) (OTCMKTS: GDFZY) soared 3.64% and closed at $23.90 on a traded volume of 59.503 shares, whereas its average trading volume is 71.863 shares. In the last three months, the stock is up19.08%. The Intra-day range for the stock is $23.62 and $23.92.
Will GDFZY Continue To Move Higher? Find Out Here
GDF SUEZ S.A. primarily purchases, produces, and markets natural gas and electricity in France and internationally. It is also involved in the transmission, storage, distribution, management, and development of gas infrastructures; and provision of energy and environmental services.
Australia and New Zealand Banking (ADR) (OTCMKTS: ANZBY) jumped 0.71% and closed at $28.43. So far in three months, the stock is up 12.46%. The 52-week range for the stock is $24.23 and $33.11 and during the previous trading session it marked $28.43 as its highest price. The stock initially exchanged hands with a price of $28.08 and the overall traded volume that day was 38.299 million shares.
Will ANZBY Continue To Move Higher? Find Out Here
Australia and New Zealand Banking Group Limited provides various banking and financial products and services to retail, small business, corporate, and institutional customers in Australia, New Zealand, the Asia Pacific region, the Middle East, Europe, and the United States.
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) after opening its shares at the price of $0.63, dropped -1.63% to close the day at $0.610. The stock ended on a traded volume of 622.535 shares, in comparison to 187.747 shares of average trading volume.
The 52-week range for the stock is $0.32 and $2.53 and during the previous trading session the stock scored the highest price of $0.63.
Will TTNP Get Buyers Even After The Recent Rally? Find Out Here
Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/